You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE Test

What Does the Evidence Reveal about Insomnia Treatment?

To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

  1. You are a member of the healthcare team seeing a 57-year-old woman who complains of 2 months of insomnia. Sleep hygiene interventions have not worked, and she requests a Z drug for insomnia. On the basis of the previous review by Treves and colleagues, what can you tell her regarding the safety of Z drugs?
    They promote higher risks for both falls and fracture
    They promote higher risks for falls, but not fracture
    They promote higher risks for fracture, but not falls
    They promote higher risks for falls only among patients with proven insomnia
  2. Which one of the following drugs was supported by the best available evidence for the management of insomnia in the current study by de Crescenzo and colleagues?
    Mirtazapine and melatonin
    Triazolam and zolpidem
    Trazodone and doxepin
    Eszoplicone and lemborexant